Sign Up Today and Learn More About Auris Health, Inc. Stock
Invest in or calculate the value of your shares in Auris Health, Inc. or other pre-IPO companies through EquityZen's platform.
Auris Health, Inc. Stock
Robotic endoscopy medical device company
About Auris Health, Inc. Stock
Founded
2007
Headquarters
San Carlos, CA, US
Total Funding
754M
Industries
Software, Data and Analytics, Artificial Intelligence
Auris Health develops robotics technology for endoscopy - a nonsurgical medical procedure used to examine a person's digestive tract. The Company currently has one offering: Monarch Platform. The Monarch Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. According to the company, its Monarch Platform improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enable new categories of care. The Company states that lung cancer is the first disease it is targeting.
Auris had been in "stealth" for nearly a decade, but in March 2018, it attained FDA approval for its Monarch Platform to be used for "bronchoscopic procedures," such as diagnosing lung cancer.
The Company was incorporated in 2007 and is based in the San Francisco Bay area.
Bronchoscopy Overview:
Source: Crunchbase; Auris
Auris Health, Inc. Press Mentions
Stay in the know about the latest news on Auris Health, Inc.
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot
Xconomy • Nov 28, 2018
Medical Robotics and Computer-Assisted Surgery Market to 2025 Analysis and In-depth Research on Market Size ...
The FentonPost • Sep 15, 2018
Computer Assisted Surgical Systems Market to Perceive Substantial Growth During 2018–2026 : Intuitive surgical, Inc ...
Newszak (blog) • Sep 08, 2018
Medical Robots Market Global Share 2018 with Growing CAGR of 21.30% by 2023
The City Chronicle • Aug 28, 2018
Medical Robot Market to witness Impressive Global Growth in Production-Consumption Ratio through 2025
theperfectinvestor.com • Jun 19, 2018
Investors in Auris Health, Inc.
Discover investors in Auris Health, Inc. stock and explore their portfolio companies
Auris Health, Inc. Management
Leadership team at Auris Health, Inc.
Co-Founder & CEO
Fred Moll
Chief Strategy Officer
Josh DeFonzo
Join now and verify your accreditation status to gain access to:
- Auris Health, Inc. current valuation
- Auris Health, Inc. stock price
- Available deals in Auris Health, Inc. and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Auris Health, Inc. stock?
Accredited investors can buy pre-IPO stock in companies like Auris Health, Inc. through EquityZen funds. These investments are made available by existing Auris Health, Inc. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Auris Health, Inc. stock?
Shareholders can sell their Auris Health, Inc. stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
